Clinical Trials Browser

Phase 1/2 × Breast Cancer Metastatic × pyrotinib × Clear all

NCT06718933 2025-02-06

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Phase 1/2 Recruiting

Breast Cancer Metastatic